Ibandronate increases the expression of the pro-apoptotic gene FAS by epigenetic mechanisms in tumor cells
Related Experiment Video
Updated: May 17, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
R Thaler1, S Spitzer, H Karlic
1Ludwig Boltzmann Institute of Osteology at the Hanusch Hospital of WGKK and AUVA Trauma Center Meidling, 1st Medical Department, Hanusch Hospital, Vienna, Austria.
Abstract:
There is growing evidence that aminobisphosphonates like ibandronate show anticancer activity by an unknown mechanism. Biochemically, they prevent posttranslational isoprenylation of small GTPases, thus inhibiting their activity. In tumor cells, activated RAS-GTPase, the founding member of the gene family, down-regulates the expression of the pro-apoptotic gene FAS via epigenetic DNA-methylation by DNMT1. We compared ibandronate treatment in neoplastic human U-2 osteosarcoma and in mouse CCL-51 breast cancer cells as well as in the immortalized non-neoplastic MC3T3-E1 osteoblastic cells. Ibandronate attenuated cell proliferation in all cell lines tested. In the neoplastic cells we found up-regulation of caspases suggesting apoptosis. Further we found stimulation of FAS-expression as a result of epigenetic DNA demethylation that was due to down-regulation of DNMT1, which was rescued by re-isoprenylation by both geranylgeranyl-pyrophosphate and farnesylpyrophosphate. In contrast, ibandronate did not affect FAS and DNMT1 expression in MC3T3-E1 non-neoplastic cells. Data suggest that bisphosphonates via modulation of the activity of small-GTPases induce apoptosis in neoplastic cells by DNA-CpG-demethylation and stimulation of FAS-expression. In conclusion the shown epigenetic mechanism underlying the anti-neoplastic activity of farnesyl-transferase-inhibition, also explains the clinical success of other drugs, which target this pathway.
Insights
Aminobisphosphonates like ibandronate induce cancer cell death by inhibiting small GTPase activity. This epigenetic mechanism involves DNA demethylation and FAS gene upregulation, leading to apoptosis in neoplastic cells.
Area of Science:
- Biochemistry
- Epigenetics
- Cancer Biology
Background:
- Aminobisphosphonates, such as ibandronate, exhibit anticancer effects through poorly understood mechanisms.
- These drugs inhibit the posttranslational isoprenylation of small GTPases, crucial for cell signaling.
- In cancer cells, activated RAS-GTPase downregulates the pro-apoptotic FAS gene via DNA methylation mediated by DNMT1.
Purpose of the Study:
- To investigate the anticancer mechanism of ibandronate in neoplastic and non-neoplastic cells.
- To determine the effect of ibandronate on cell proliferation, apoptosis, and gene expression.
- To elucidate the role of epigenetic modifications, specifically DNA methylation and demethylation, in ibandronate's action.
Main Methods:
- Treatment of human osteosarcoma (U-2) and mouse breast cancer (CCL-51) cells, alongside non-neoplastic osteoblastic (MC3T3-E1) cells, with ibandronate.
- Assessment of cell proliferation rates across all cell lines.
- Analysis of caspase activation, FAS expression, DNMT1 levels, and DNA methylation status following ibandronate treatment.
- Investigation of the rescue effect of geranylgeranyl-pyrophosphate and farnesylpyrophosphate on DNMT1 activity.
Main Results:
- Ibandronate attenuated proliferation in all tested cell lines.
- Neoplastic cells exhibited increased caspase activity, indicating apoptosis.
- FAS expression was upregulated in cancer cells due to DNA demethylation, linked to DNMT1 downregulation.
- DNMT1 downregulation was reversible by re-isoprenylation, while non-neoplastic cells showed no changes in FAS or DNMT1 expression.
Conclusions:
- Bisphosphonates induce apoptosis in neoplastic cells by modulating small GTPase activity, leading to DNA-CpG demethylation and FAS expression stimulation.
- This epigenetic mechanism explains the anti-neoplastic activity of farnesyl-transferase inhibition.
- The findings provide insight into the clinical efficacy of drugs targeting this pathway.
More Related Videos
04:20Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Intracellular Signaling Affects Focal Adhesions
Some...
Abnormal Proliferation
TGF - β Signaling Pathway